Eads & Heald Wealth Management trimmed its holdings in Procter & Gamble Co (NYSE:PG) by 2.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,644 shares of the company’s stock after selling 442 shares during the quarter. Procter & Gamble comprises 1.4% of Eads & Heald Wealth Management’s portfolio, making the stock its 14th largest holding. Eads & Heald Wealth Management’s holdings in Procter & Gamble were worth $2,349,000 as of its most recent SEC filing.
A number of other hedge funds have also modified their holdings of PG. Eukles Asset Management lifted its position in shares of Procter & Gamble by 67.5% during the 2nd quarter. Eukles Asset Management now owns 1,189 shares of the company’s stock valued at $142,000 after acquiring an additional 479 shares during the last quarter. Mattern Wealth Management LLC lifted its position in shares of Procter & Gamble by 3.3% during the 2nd quarter. Mattern Wealth Management LLC now owns 20,518 shares of the company’s stock valued at $2,453,000 after acquiring an additional 647 shares during the last quarter. Main Street Research LLC lifted its position in shares of Procter & Gamble by 1.8% during the 2nd quarter. Main Street Research LLC now owns 367,679 shares of the company’s stock valued at $43,963,000 after acquiring an additional 6,410 shares during the last quarter. Sciencast Management LP lifted its holdings in shares of Procter & Gamble by 51.1% in the second quarter. Sciencast Management LP now owns 23,643 shares of the company’s stock valued at $2,951,000 after purchasing an additional 7,993 shares in the last quarter. Finally, Pacer Advisors Inc. purchased a new stake in shares of Procter & Gamble in the second quarter valued at $25,876,000. 63.33% of the stock is owned by institutional investors and hedge funds.
A number of analysts have recently issued reports on the company. Morgan Stanley increased their target price on Procter & Gamble from $134.00 to $144.00 and gave the company an “overweight” rating in a report on Friday. Jefferies Financial Group increased their target price on Procter & Gamble from $140.00 to $148.00 and gave the company a “buy” rating in a report on Monday, July 27th. Stifel Nicolaus increased their target price on Procter & Gamble from $117.00 to $129.00 and gave the company a “buy” rating in a report on Monday, April 20th. Royal Bank of Canada restated a “hold” rating and issued a $120.00 target price on shares of Procter & Gamble in a report on Tuesday, April 14th. Finally, TheStreet upgraded Procter & Gamble from a “c+” rating to a “b” rating in a report on Tuesday, April 14th. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Procter & Gamble has a consensus rating of “Buy” and a consensus price target of $133.67.
In other Procter & Gamble news, CFO Jon R. Moeller sold 130,626 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $116.37, for a total transaction of $15,200,947.62. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Nelson Peltz sold 404,714 shares of the stock in a transaction on Friday, May 15th. The stock was sold at an average price of $113.01, for a total transaction of $45,736,729.14. Following the transaction, the director now directly owns 3,891 shares in the company, valued at $439,721.91. The disclosure for this sale can be found here. Insiders have sold 1,570,603 shares of company stock worth $179,504,390 over the last three months. Company insiders own 1.75% of the company’s stock.
NYSE PG opened at $131.12 on Friday. Procter & Gamble Co has a 1-year low of $94.34 and a 1-year high of $132.03. The company has a current ratio of 0.85, a quick ratio of 0.66 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $325.35 billion, a PE ratio of 26.44, a price-to-earnings-growth ratio of 3.44 and a beta of 0.42. The firm’s fifty day simple moving average is $121.39 and its 200-day simple moving average is $119.14.
Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Thursday, July 30th. The company reported $1.16 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.15. The business had revenue of $17.70 billion for the quarter, compared to the consensus estimate of $16.97 billion. Procter & Gamble had a net margin of 18.36% and a return on equity of 29.38%. Procter & Gamble’s revenue for the quarter was up 3.5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.10 earnings per share. As a group, analysts predict that Procter & Gamble Co will post 5.3 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, August 17th. Shareholders of record on Friday, July 24th will be given a dividend of $0.7907 per share. This represents a $3.16 annualized dividend and a yield of 2.41%. The ex-dividend date is Thursday, July 23rd. Procter & Gamble’s payout ratio is 61.72%.
Procter & Gamble Company Profile
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.
Further Reading: What do I need to know about analyst ratings?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Co (NYSE:PG).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.